DN44 Acceleron extension

Clinical Trial Grant

Duke Scholars

Principal Investigator Jeffrey Guptill Neurology, Neuromuscular Disease

Administered By

Duke Clinical Research Institute

Awarded By

Acceleron Pharma

Start Date

April 12, 2019

End Date

July 1, 2021

Administered By

Duke Clinical Research Institute

Awarded By

Acceleron Pharma

Start Date

April 12, 2019

End Date

July 1, 2021